Featuring multimedia and clinical findings from the new england journal of medicine Ai startup openevidence is raising a fresh round of capital from sequoia to scale its chatbot for doctors Featuring multimedia and clinical findings from jama and the jama network specialty journals.
Ysljlexis | Instagram, TikTok | Linktree
Openevidence is an american artificial intelligence company that develops a medical search engine used by physicians for clinical decision support
The company was founded in 2022 by entrepreneur daniel nadler and is headquartered in miami, florida.
Openevidence, which forbes profiled in july, has been signing up users fast To not just help doctors find existing medical research, but to create medical superintelligence. Las vegas, nev.—artificial intelligence startup openevidence banked $200 million in series c funding, just three months after it Openevidence, a tool that doctors and nurses have likened to chatgpt for medicine, plans to announce a $200 million raise at a $6 billion valuation, the new york times reports.
Openevidence secures $200 million at $6b valuation to provide verified ai insights for clinicians, helping doctors make evidenced decisions. Stay up to date on all the new findings that matter The leading medical information platform.